Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
New York State Psychiatric Institute Columbia University |
---|---|
Information provided by: | New York State Psychiatric Institute |
ClinicalTrials.gov Identifier: | NCT00619411 |
The purpose of this study is to examine the feasibility and acceptability of an adaptation of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) that includes greater and more structured involvement of the parents in the treatment.
Condition | Intervention | Phase |
---|---|---|
Major Depression Dysthymic Disorder Adjustment Disorders Depressive Disorder Not Otherwise Specified |
Behavioral: Interpersonal Therapy for Depressed Adolescents & Parents |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | An Open Clinical Trial of Interpersonal Psychotherapy for Depressed Adolescents and Parents |
Study Start Date: | November 2007 |
Arms | Assigned Interventions |
---|---|
I: Experimental | Behavioral: Interpersonal Therapy for Depressed Adolescents & Parents |
Adolescent depression is a significant public health problem, and it increases the risk of poor psychosocial outcomes in adolescence and adulthood. Interpersonal Psychotherapy for Depressed Adolescents (IPT-A) has been found to be an effective treatment for reducing adolescents' depressive symptoms and improving their global and social functioning. The purpose of the current study is to examine the feasibility and acceptability of IPT-A when it is delivered with greater and more structured involvement of the parents in the treatment.
Participants will receive 15 weeks of Interpersonal Psychotherapy for Depressed Adolescents and Parents (IPT-AP). Eight the therapy sessions are conducted with the adolescent individually, two are with the parent(s) individually, and five are conducted with the adolescent and parent(s) together. At the end of the 15 weeks, participants who have demonstrated at least a 50% reduction in depressive symptoms will participate in three booster sessions delivered on a monthly basis. All participants will be assessed at baseline, week 5, week 10, week 15 (post-treatment), and 3 months post-treatment to measure depressive symptoms, global and social functioning, and attitudes toward treatment.
Ages Eligible for Study: | 12 Years to 18 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Meredith Gunlicks, Ph.D. | 212-543-5812 | Gunlickm@childpsych.columbia.edu |
Contact: Laura Mufson, Ph.D. | 212-543-5561 | MufsonL@childpsych.columbia.edu |
United States, New York | |
Columbia University/New York State Psychiatric Institute | Recruiting |
New York, New York, United States, 10032 | |
Contact: Meredith Gunlicks, Ph.D. 212-543-5812 Gunlickm@childpsych.columbia.edu | |
Principal Investigator: Meredith Gunlicks, Ph.D. |
Principal Investigator: | Meredith Gunlicks, Ph.D. | Columbia University/New York State Psychiatric Institute |
Responsible Party: | Columbia University/New York State Psychiatric Institute ( Meredith Gunlicks, Ph.D. ) |
Study ID Numbers: | 5549 |
Study First Received: | February 11, 2008 |
Last Updated: | April 30, 2008 |
ClinicalTrials.gov Identifier: | NCT00619411 |
Health Authority: | United States: Institutional Review Board |
Major Depression Dysthymic Disorder Adjustment Disorder With Depressed Mood Depressive |
Disorder Not Otherwise Specified Adolescent Psychotherapy |
Adjustment Disorders Depression Mental Disorders Mood Disorders |
Dysthymic Disorder Depressive Disorder, Major Depressive Disorder Behavioral Symptoms |
Pathologic Processes Disease |